{{Rsnum
|rsid=192303
|Chromosome=16
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=SLC6A2
|position=55666312
|Gene_s=SLC6A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 11.5 | 46.9 | 41.6
| HCB | 2.2 | 18.2 | 79.6
| JPT | 1.8 | 23.0 | 75.2
| YRI | 7.5 | 44.2 | 48.3
| ASW | 5.3 | 47.4 | 47.4
| CHB | 2.2 | 18.2 | 79.6
| CHD | 0.0 | 21.1 | 78.9
| GIH | 2.0 | 28.7 | 69.3
| LWK | 18.2 | 42.7 | 39.1
| MEX | 0.0 | 29.3 | 70.7
| MKK | 12.8 | 42.9 | 44.2
| TSI | 9.8 | 49.0 | 41.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=25229170
|Title=Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}